Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Development Status

Other

3

US Previously Marketed

1

All Match

Any Match

Exclude Selected

Exclude Selected

Primary Target

Aldehyde dehydrogenase

1

Estrogen receptor alpha

1

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

Unknown

3

1983

1

All Match

Any Match

Exclude Selected

Exclude Selected

Condition

Unknown

1

All Match

Any Match

Exclude Selected

Exclude Selected

Originator

Standard Oil Dev

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Chemical

4

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

CAS

4

CHEBI

4

FDA UNII

4

PUBCHEM

4

EPA CompTox

3

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Principal Form

3

Salts, Hydrates, Esters, etc.

1

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 1 - 4 of 4 results

First page disabled
Previous page disabled
1
Next page disabled
Next page disabled

OXADIXYL

236CMA8A12

Export Data
Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

DIMETHOMORPH, (Z)-

37V7980RBV

Export Data
Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

CAPTAN

EOL5G26Q9F

Export Data
Search for Structure

Status:

US Previously Marketed

First approved in 1983

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

Estrogen receptor alpha

Aldehyde dehydrogenase

Conditions:

Captan is a fungicide. It is used on a variety of agricultural and greenhouse food/feed crops, indoor non-food uses, seed treatments and ornamental plant sites. People who mixed captan products or worked in fields where captan had been applied report...

ed eye and skin irritation. A few human volunteers reported skin irritation and allergic reactions after captan was applied to their backs. Captan was previously cited as Group B2, a probable human carcinogen by the US Environmental Protection Agency (EPA), but was reclassified in 2004. The EPA now states: “Captan is not likely to be a human carcinogen nor pose cancer risks of concern when used in accordance with approved product labels.”

DIMETHOMORPH, (E)-

NU7EH56J7K

Export Data
Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1